Prelude Therapeutics
Price & Volume
Stats
See moreOpen | $0.80 |
Previous Close | $0.81 |
Day Range | $0.78-$0.83 |
52W Range | $0.61-$6.80 |
Market Cap | $44.6M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $7M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $7M |
Diluted EPS | -$1.68 |
News
See moreYahoo Finance • last month
Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025
Yahoo Finance • 2 months ago
Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference
Yahoo Finance • last year
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Prelude Therapeutics Incorporated (NASDAQ: PRLD) and Encourages Investors to Contact the Firm
Yahoo Finance • last year
Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses
About
CEO | Dr. Krishna Vaddi D.V.M., Ph.D. |
CFO | Mr. Bryant David Lim J.D. |
Address | 175 Innovation Boulevard, Wilmington, DE, United States, 19805 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |
